An affiliate of Waypoint Capital (Waypoint) has acquired a 70 per cent stake in Allergy Partners (Allergy Partners), a US group of single-specialty allergy and asthma practices.
Allergy Partners will continue to be led by current Chief Executive Officer, David Brown. Terms of the transaction have not been disclosed.
